Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance

April 2, 2026 updated by: Universidade do Porto

Effects of Manipulating Food Intake Sequence in the Pre-exercise Meal on Substrate Utilisation and Endurance Performance in Athletes

The goal of this clinical trial is to understand how consuming a pre-exercise meal in different food intake sequences affects substrate utilisation and endurance exercise performance in healthy trained athletes. Specifically, the main questions it aims to answer are:

  • Does consuming the pre-exercise meal in different food intake sequences alter the whole-body utilisation of fat and CHO at rest and during prolonged exercise at moderate to heavy intensities?
  • Does consuming the pre-execise meal in different food intake sequences alter time-trial performance?
  • Does consuming the pre-exercise meal in different food intake sequences alter other metabolic and physiological responses before, during or after exercise (i.e., blood glucose, blood lactate, heart rate (HR), ratings of perceived exertion (RPE), appetite)?

To address these questions, researchers will compare eating the dietary sources of rapidly absorbed CHO at the end (CHO-last meal pattern) or at the start (CHO-first meal pattern) of a standardised pre-exercise meal, in a randomised, counterbalanced, crossover design. Two hours after starting the pre-exercise meal, participants will perform a 60-min submaximal test on a cycling ergometer at two different intensities (30 min at 90% of the ventilatory threshold (VT) 1 and 30 min at 50% VT1-VT2), followed by a 10-km cycling time trial (TT).

In the screening visit participants will:

  • Be screened for cardiometabolic conditions
  • Perform an 8-12-min graded exercise test to determine their maximal pulmonary oxygen uptake (VO2max) and non-invasive submaximal anchors of performance (VT 1 and VT 2)
  • Be familiarised to the experimental procedures

In experimental visits participants will:

  • Follow guidelines pertaining to dietary intake, exercise and sleep in the previous 24 hours
  • Have a standardised test meal in either the CHO-last or CHO-first food intake sequence
  • Have 3 drops of capillary blood (0,9 µL in total) collected to measure glucose and lactate pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, every 15 min during submaximal exercise and post-TT
  • Breathe into an indirect calorimetry mask for 5 min pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, every 15 min during submaximal exercise and post-TT
  • Wear a HR monitor continuously during submaximal exercise and the TT
  • Rate their appetite on visual analogue scales pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, and 30 min post-TT
  • Rate their perceived exertion on RPE scales every 15 min during submaximal exercise, post-TT and 30 min post-TT.

Data will be compared within-participant between food intake sequences using linear mixed-effects models with random intercepts, to account for repeated measurements, interindividual variability, and potential missing data.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Oeiras
      • Lisbon, Oeiras, Portugal, 1495-433
        • Recruiting
        • Cidade do Futebol
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult (18-64 years old)
  • Men
  • Endurance-trained athletes (meeting training and performance caliber criteria ≥Tier 2; McKay et al., 2022)
  • Healthy (meeting the exclusion criteria for medical conditions)
  • Normal glucose tolerant according to the latest criteria established by the American Diabetes Association (2024): HbA1c <5.7%, fasting plasma glucose <5.6 mmol/L (100 mg/dL) or 2-h plasma glucose <7.8 mmol/L (140 mg/dL) during a 75-g OGTT
  • Able and willing to provide informed consent and safely comply with study procedures

Exclusion Criteria:

  • Any medical condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias into the experiment (e.g. cardiovascular disease; alcohol or substance abuse; any condition affecting the glucose or lipid metabolism, reviewed on a case by case basis)
  • Any reported medication or supplementation that may interfere with the glucose metabolism (e.g., acarbose, insulin, metformin, semaglutide, thiazolidinediones, sulfonylureas, corticosteroids, thiazide diuretics) or lipid metabolism (e.g., statins, nicotinic acid, colestyramine anhydrous, ezetimibe, fibrates, L-carnitine). Other medication and supplementation will be reviewed on a case by case basis.
  • Known food allergy, intolerance or hypersensitivity to any of the test meal ingredients
  • Recent change in body mass (± 2 kg in the last 2 months)
  • Smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CL-CF
The interventions (carbohydrate-last meal pattern (CL) or carbohydrate-first meal pattern (CF)) will be delivered in random order at two study visits, separated by a wash-out period of at least 7 days. If participants are allocated to this study arm, they will receive the CL on the first visit and the CF on the second visit. The nutritional composition of the test-meal will comply to the current sports nutrition guidelines for the pre-exercise meal (i.e., 1-4 g of CHO/kg of body mass, moderate amounts of protein, low-fat and fibre content, 5-10 mL/kg of body mass of fluids) (Thomas et al., 2016). Participants will be encouraged to consume the meal in full within 15 minutes, at a comfortable pace, to mimic real eating circumstances.
Skyr yoghurt, whey protein and almonds over ~5 min, immediately followed by white bread, strawberry jam, banana and pulp-free orange juice over ~10 min.
Other Names:
  • CL
  • CHO-last
White bread, strawberry jam, banana and pulp-free orange juice over ~10 min, immediately followed by skyr yoghurt, whey protein and almonds over ~5 min.
Other Names:
  • CF
  • CHO-first
Active Comparator: CF-CL
The interventions (carbohydrate-last meal pattern (CL) or carbohydrate-first meal pattern (CF)) will be delivered in random order at two study visits, separated by a wash-out period of at least 7 days. If participants are allocated to this study arm, they will receive the CF on the first visit and the CL on the second visit. The test-meal will be identical and isocaloric in both interventions of the study.
Skyr yoghurt, whey protein and almonds over ~5 min, immediately followed by white bread, strawberry jam, banana and pulp-free orange juice over ~10 min.
Other Names:
  • CL
  • CHO-last
White bread, strawberry jam, banana and pulp-free orange juice over ~10 min, immediately followed by skyr yoghurt, whey protein and almonds over ~5 min.
Other Names:
  • CF
  • CHO-first

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Whole-body fat oxidation
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Difference between CHO-last and CHO-first meal patterns in the whole-body fat oxidation rate (g/min) over time adjusted for baseline, measured by indirect calorimetry.
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Time-trial performance
Time Frame: Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)
Difference between CHO-last and CHO-first meal patterns in the time to complete (min:sec) a 10-km cycling TT, assessed using a validated cycle ergometer.
Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time-trial power output
Time Frame: Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)
Difference between CHO-last and CHO-first meal patterns in the average power output (W) during a 10-km cycling TT, assessed using a validated cycle ergometer.
Immediately upon completion of the time trial subsequent to the post-meal resting period (0-120 minutes) and standardised exercise protocol (120-180 minutes)
Whole-body CHO oxidation
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Difference between CHO-last and CHO-first meal patterns in the whole-body CHO oxidation rate (g/min) over time adjusted for baseline, measured by indirect calorimetry.
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Respiratory exchange ratio (RER)
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Difference between CHO-last and CHO-first meal patterns in the RER over time adjusted for baseline, measured by indirect calorimetry.
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Energy expenditure
Time Frame: Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Difference between CHO-last and CHO-first meal patterns in the energy expenditure rate (kcal/min) over time adjusted for baseline, measured by indirect calorimetry.
Every 15 minutes post-meal (0-120 minutes), every 15 minutes throughout the subsequent standardised exercise protocol (120-180 minutes)
Blood glucose concentrations
Time Frame: Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
Difference between CHO-last and CHO-first meal patterns in the capillary blood glucose concentrations (mmol/L) over time adjusted for baseline, measured by a validated glucometer.
Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
Blood lactate concentrations
Time Frame: Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
Difference between CHO-last and CHO-first meal patterns in the capillary blood lactate concentrations (mmol/L) over time adjusted for baseline, measured by a validated lactate meter.
Every 15 minutes post-meal in the first hour (0-60 min), every 30 minutes in the second hour (60-120 min), every 15 minutes throughout the standardised exercise protocol (120-180 min) and immediately upon completion of the subsequent time trial
Heart Rate
Time Frame: Continuously throughout the standardised exercise protocol (120-180 minutes) and subsequent time trial
Difference between CHO-last and CHO-first meal patterns in the heart rate (bpm) over time adjusted for baseline, assessed as 15-minute averages during exercise using a validated heart rate monitor.
Continuously throughout the standardised exercise protocol (120-180 minutes) and subsequent time trial
Ratings of perceived exertion (RPE)
Time Frame: Every 15 minutes during the standardised exercise protocol (120-180 minutes), immediately upon completion of the subsequent time trial, 30 minutes after completion of the time trial
Difference between CHO-last and CHO-first meal patterns in the absolute RPE over time, assessed during and after exercise using the validated modified Borg's 0-10 scale.
Every 15 minutes during the standardised exercise protocol (120-180 minutes), immediately upon completion of the subsequent time trial, 30 minutes after completion of the time trial
Subjective appetite ratings
Time Frame: Every 15 minutes post-meal in the first hour (0-60 minutes), every 30 minutes in the second hour (60-120 minutes), and 30 minutes after completion of the time trial
Difference between CHO-last and CHO-first meal patterns in the appetite ratings (mm) over time adjusted for baseline, assessed at rest and after exercise using validated 100-mm visual analogue scales.
Every 15 minutes post-meal in the first hour (0-60 minutes), every 30 minutes in the second hour (60-120 minutes), and 30 minutes after completion of the time trial

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rita Giro, FCNAUP, University of Porto; Federação Portuguesa de Futebol

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

March 26, 2026

First Posted (Actual)

March 31, 2026

Study Record Updates

Last Update Posted (Actual)

April 3, 2026

Last Update Submitted That Met QC Criteria

April 2, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FOODSEQ-SUEP
  • 2022.12954.BD (Other Grant/Funding Number: Fundação para a Ciência e Tecnologia)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised IPD will be made available upon reasonable request directed to the corresponding author.

IPD Sharing Time Frame

IPD will become accessible following the publication of all study findings.

IPD Sharing Access Criteria

IPD will be made available to researchers with legitimate scientific purposes (such as systematic reviews or meta-analyses).

IPD Sharing Supporting Information Type

  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Participants

Clinical Trials on Carbohydrate-last meal pattern

Subscribe